While several clinical trials are underway across the world to test the efficacy of convalescent plasma therapy, the results from these studies are limited.
India has said it is monitoring the US FDA updates, which said an extended-release variant of the drug had higher levels of a cancer-causing substance.
The move could mark a breakthrough in screening for the coronavirus as health professionals argue that swift screening is essential to temper new outbreaks.
US FDA Commissioner Stephen Hahn & CDC Director Robert Redfield's exposure comes days after several aides working in the White House tested positive for the virus.
New Delhi: During Operation Sindoor, the United States which had received intelligence suggesting that India had launched BrahMos cruise missiles to strike targets inside...
COMMENTS